Genome science at the interface of
disease, evolution, and biotechnology

We are a hybrid experimental and computational group dedicated to understanding genotype-phenotype relationships, developing new omics technologies, and providing rigorous scientific training. Focusing primarily on the genome and the brain, our research promises to derive mechanistic insights into neurodevelopmental disorders, uncover genomic contributors to human evolution, and unlock new opportunities for research and precision therapeutics.